Portfolio Company · Operating Co.

Alcresta Therapeutics

Not on record

backed byLinden Capital Partners

Current

a portfolio company of

Linden Capital Partners

Status on record: Current

PE Firm Index

Who owns Alcresta Therapeutics?

Alcresta Therapeutics is listed as a current portfolio company of Linden Capital Partners on Linden Capital Partners' own portfolio page.

Company Snapshot

Alcresta Therapeutics' owner on record, Linden Capital Partners, is a private equity firm headquartered in Chicago, USA. Linden Capital Partners lists 54 companies in the index.

SectorNot on record

Parent PE firmLinden Capital Partners

Ownership statusCurrent

WebsiteNot on record

About the owner

Linden Capital Partners

Headquarters: Chicago, USA
Strategy: Private equity, Structured capital
Sectors: Healthcare
Companies in the index: 54

Linden Capital Partners is a healthcare private equity firm that invests in healthcare companies.

Read the Linden Capital Partners profile

Deals involving Alcresta Therapeutics

Linden Capital Partnersplatform

Linden Capital Partners acquired Alcresta Therapeutics, Inc.

alcresta.com

Questions about Alcresta Therapeutics

Who owns Alcresta Therapeutics?

Alcresta Therapeutics is listed as a current portfolio company of Linden Capital Partners on Linden Capital Partners' own portfolio page.

Where is Linden Capital Partners headquartered?

Linden Capital Partners is headquartered in Chicago, USA.

Sources

Linden Capital Partners
https://www.linden.com/portfolio/investments/

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Alcresta Therapeutics and does not provide investment advice.

Other portfolio companies of Linden Capital Partners

6 of 53 shown

See the full Linden Capital Partners portfolio.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Linden Capital Partners

Chicago, USA

Status: Current

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.